Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Blumenthal

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumorO C Boerman, R M Sharkey, G Y Wong, et al.
Journal of the National Cancer Institute|March 15, 1989
Cytotoxicity of receptor-mediated 16 alpha-[125I]iodoestradiol in cultured MCF-7 human breast cancer cellsW H McLaughlin, R A Milius, K M Pillai, et al.
Journal of the National Cancer Institute|May 1, 1991
Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude miceR M Sharkey, K S Weadock, A Natale, et al.
Cancer|December 24, 1997
Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodiesM E Juweid, C H Zhang, R D Blumenthal, et al.
International Journal of Cancer|December 18, 2001
Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxiaR D Blumenthal, A Taylor, L Osorio, et al.
Cancer Research|August 1, 1996
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colonR D Blumenthal, R Stein, R M Sharkey, et al.
International Journal of Cancer|June 4, 1998
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer modelT M Behr, G Sgouros, V Vougiokas, et al.
International Journal of Cancer|July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinomaR M Sharkey, R D Blumenthal, T M Behr, et al.
Bioconjugate Chemistry|July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft modelR M Sharkey, H Karacay, G L Griffiths, et al.
Cancer Research|November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodiesR D Blumenthal, R M Sharkey, L Haywood, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumorO C Boerman, R M Sharkey, G Y Wong, et al.
Journal of the National Cancer Institute|March 15, 1989
Cytotoxicity of receptor-mediated 16 alpha-[125I]iodoestradiol in cultured MCF-7 human breast cancer cellsW H McLaughlin, R A Milius, K M Pillai, et al.
Journal of the National Cancer Institute|May 1, 1991
Successful radioimmunotherapy for lung metastasis of human colonic cancer in nude miceR M Sharkey, K S Weadock, A Natale, et al.
Cancer|December 24, 1997
Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodiesM E Juweid, C H Zhang, R D Blumenthal, et al.
International Journal of Cancer|December 18, 2001
Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxiaR D Blumenthal, A Taylor, L Osorio, et al.
Cancer Research|August 1, 1996
Antibody penetration of tumor GS-7 xenografts in nude mice: a model for mucinous adenocarcinoma of the colonR D Blumenthal, R Stein, R M Sharkey, et al.
International Journal of Cancer|June 4, 1998
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer modelT M Behr, G Sgouros, V Vougiokas, et al.
International Journal of Cancer|July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinomaR M Sharkey, R D Blumenthal, T M Behr, et al.
Bioconjugate Chemistry|July 1, 1997
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft modelR M Sharkey, H Karacay, G L Griffiths, et al.
Cancer Research|November 1, 1992
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodiesR D Blumenthal, R M Sharkey, L Haywood, et al.
Pageof 6